...
首页> 外文期刊>Molecular cell >RIG-I Modulates Src-Mediated AKT Activation to Restrain Leukemic Stemness
【24h】

RIG-I Modulates Src-Mediated AKT Activation to Restrain Leukemic Stemness

机译:RIG-I调节Src介导的AKT激活以抑制白血病。

获取原文
获取原文并翻译 | 示例
           

摘要

Retinoic acid (RA)-inducible gene I (RIG-I) is highly upregulated and functionally implicated in the RA-induced maturation of acute myeloid leukemia (AML) blasts. However, the underlying mechanism and the biological relevance of RIG-I expression to the maintenance of leukemogenic potential are poorly understood. Here, we show that RIG-I, without priming by foreign RNA, inhibits the Src-facilitated activation of AKT-mTOR in AML cells. Moreover, in a group of primary human AML blasts, RIG-I reduction renders the Src family kinases hyperactive in promoting AKT activation. Mechanistically, a PxxP motif in RIG-I, upon the N-terminal CARDs' association with the Src SH1 domain, competes with the AKT PxxP motif for recognizing the Src SH3 domain. In accordance, mutating PxxP motif prevents Rig-I from inhibiting AKT activation, cytokine-stimulated myeloid progenitor proliferation, and invivo repopulating capacity of leukemia cells. Collectively, our data suggest an antileukemia activity of RIG-I via competitively inhibiting Src/AKT association.
机译:维甲酸(RA)诱导基因I(RIG-I)在RA诱导的急性髓细胞白血病(AML)胚成熟中高度上调,并且在功能上有牵连。然而,人们对RIG-I表达与维持白血病发生潜能的潜在机制和生物学相关性了解甚少。在这里,我们显示RIG-I无需外源RNA引发即可抑制AML细胞中Src促进的AKT-mTOR激活。此外,在一组主要的人类AML原始细胞中,RIG-I的还原使Src家族激酶在促进AKT激活中活性较高。从机理上讲,RIG-I中的PxxP基序在N末端CARD与Src SH1域结合后,与AKT PxxP基序竞争以识别Src SH3域。相应地,突变PxxP基序防止Rig-1抑制AKT活化,细胞因子刺激的髓样祖细胞增殖以及白血病细胞的体内繁殖能力。总的来说,我们的数据表明RIG-1的抗白血病活性是通过竞争性抑制Src / AKT缔合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号